CLB Core Laboratories N V

  1. Stocks
  2. Energy
  3. NYSE: CLB

Price (delayed)

$23.13

Market cap

$1.08B

P/E Ratio

45.35

Dividend/share

$0.04

EPS

$0.51

Enterprise value

$1.3B

Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 ...

Highlights
CLB's net income has soared by 144% year-on-year and by 22% since the previous quarter
Core Laboratories N V's EPS has soared by 143% YoY and by 21% from the previous quarter
CLB's debt is up by 6% from the previous quarter but it is down by 6% YoY
Sector: Energy
Industry: Oil & Gas Equipment & Services
Website: http://www.corelab.com
Peers: HAL SLB OII HLX

Key stats

What are the main financial stats of CLB
Market
Shares outstanding
46.66M
Market cap
$1.08B
Enterprise value
$1.3B
Valuations
Price to earnings (P/E)
45.35
Price to book (P/B)
5.52
Price to sales (P/S)
2.15
EV/EBIT
26.95
EV/EBITDA
20.03
EV/Sales
2.58
Earnings
Revenue
$502.79M
EBIT
$48.17M
EBITDA
$64.82M
Free cash flow
$8.33M
Per share
EPS
$0.51
Free cash flow per share
$0.18
Book value per share
$4.19
Revenue per share
$10.78
TBVPS
$10.44
Balance sheet
Total assets
$593.62M
Total liabilities
$393.47M
Debt
$235.31M
Equity
$195.39M
Working capital
$132.3M
Liquidity
Debt to equity
1.2
Current ratio
2.38
Quick ratio
1.33
Net debt/EBITDA
3.38
Margins
EBITDA margin
12.9%
Gross margin
20.8%
Net margin
4.7%
Operating margin
9.6%
Efficiency
Return on assets
4.1%
Return on equity
13%
Return on invested capital
8.1%
Return on capital employed
9.7%
Return on sales
9.6%
Dividend
Dividend yield
0.17%
DPS
$0.04
Payout ratio
7.8%

CLB stock price

How has the Core Laboratories N V stock price performed over time
Intraday
1.14%
1 week
6.15%
1 month
10.94%
1 year
-13.98%
YTD
14.11%
QTD
4.9%

Financial performance

How have Core Laboratories N V's revenue and profit performed over time
Revenue
$502.79M
Gross profit
$104.56M
Operating income
$48.4M
Net income
$23.71M
Gross margin
20.8%
Net margin
4.7%
CLB's net income has soared by 144% year-on-year and by 22% since the previous quarter
CLB's net margin has soared by 135% YoY and by 18% from the previous quarter
Core Laboratories N V's operating income has increased by 46% YoY and by 17% QoQ
The operating margin has increased by 37% YoY and by 13% from the previous quarter

Growth

What is Core Laboratories N V's growth rate over time

Valuation

What is Core Laboratories N V stock price valuation
P/E
45.35
P/B
5.52
P/S
2.15
EV/EBIT
26.95
EV/EBITDA
20.03
EV/Sales
2.58
Core Laboratories N V's EPS has soared by 143% YoY and by 21% from the previous quarter
The stock's price to earnings (P/E) is 23% less than its last 4 quarters average of 59.2 and 14% less than its 5-year quarterly average of 52.8
The P/B is 55% below the 5-year quarterly average of 12.4 but 15% above the last 4 quarters average of 4.8
CLB's equity is up by 21% YoY and by 6% from the previous quarter
CLB's price to sales (P/S) is 28% lower than its 5-year quarterly average of 3.0 but 19% higher than its last 4 quarters average of 1.8
The company's revenue rose by 5% YoY and by 2.7% QoQ

Efficiency

How efficient is Core Laboratories N V business performance
The ROA has soared by 141% YoY and by 21% from the previous quarter
The return on equity has surged by 110% year-on-year and by 16% since the previous quarter
The return on invested capital has surged by 53% year-on-year and by 17% since the previous quarter
Core Laboratories N V's ROS has increased by 39% YoY and by 14% from the previous quarter

Dividends

What is CLB's dividend history
Dividend details
DPS
$0.04
Dividend yield
0.17%
Payout ratio
7.8%
Recent dividends

Financial health

How did Core Laboratories N V financials performed over time
The total assets is 51% greater than the total liabilities
CLB's current ratio is up by 17% year-on-year and by 16% since the previous quarter
The quick ratio has increased by 12% QoQ and by 10% YoY
CLB's debt is 20% more than its equity
The debt to equity has decreased by 22% YoY
CLB's equity is up by 21% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.